Healthcare-focused investment firm Deerfield Management Company has secured $1.6bn for its third fund.
With the new fund, Deerfield will continue its strategy of investing in various segments of the healthcare industry including biotechnology, pharmaceuticals, medical devices, healthcare services, and animal health.
Earlier this month AltAssets reported that Deerfield was targeting $1.6bn for its new fund.
Deerfield has $3bn of public healthcare investments under management and has raised $1.5bn across its first two funds.
Deerfield Private Design II is currently in the final stages of committing around $1bn.
Deerfield managing partner James Flynn said, “Deerfield is proud to play a leading role in advancing innovation in the development and delivery of healthcare products and services through investment, information and philanthropy. Few other industries can have such a profound impact on the quality and length of life.”
Copyright © 2014 AltAssets